MedPath

Comparition of Flaxseed and Evening Primrose oil with Vitamin E on Cyclic Mastalgia in wome

Phase 2
Conditions
Mastodynia
cyclic mastalgia.
Registration Number
IRCT2015072123281N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

inclusion criteria: cyclical mastalgia for 5 days or more in luteal phase for 2 menstrual cycle; mastalgia intensity of 4 or above based on visual analogue scale in the last cycle; aged 18 to 45 years; having literacy to read and write; living in Mashhad; Informed consent; body mass index between19-29; not taking any drugs for mastalgia in the last 3 month; regular menstrual cycles between 21 and 35 days; Lack of any cases of abnormality in clinical breast examination; not having the history of breast cancer or any kind of breast tumor in the person or first degree relatives like mother or sister; not being willing to get pregnant until the end of the study; not being in the lactation period; having no history of any kind of tumor and cancer in other organs; not being on a specific diet; having no history of any systemic and psychological diseases; lack of a history of breast surgery and injection gel; lack of constipation
exclusion criteria:pregnancy; taking any hormonal drugs like contraception pills; experiencing unexpected eventsduring studt; starting any kind of new lifestyle; having allergy or intolerance of supplements or side effects of drugs during study; disruption of eating flaxseed powder or capsuls tor frequent 3 days or constant 5 days; relinquishment to complete the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of cyclic breast pain. Timepoint: at the begining of the study- at the end of first cycle of intervention- at the end of the second sycle of intervention. Method of measurement: visual analog scale.;Duration of the breast pain. Timepoint: at the begining of the study- at the end of first cycle of intervention- at the end of the second sycle of intervention. Method of measurement: number of days in the related form.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath